|
Talikabtagene Autoleucel Clinical Trials
1 actively recruiting trial
Pipeline
Phase 2/3: 1
Top Sponsors
- Health Institutes of Turkey1
Indications
- Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia (B-ALL)1
- High-grade B-cell Lymphoma (HGBCL)1
- Relapsed/Refractory Non-Hodgkin Lymphoma1
- Follicular Lymphoma ( FL)1
- Diffuse Large B-cell Lymphoma(DLBCL)1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.